Wed, Apr 16, 2014, 7:57 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Dendreon Corp. Message Board

  • davecarneyinc davecarneyinc May 25, 2012 4:20 PM Flag

    34% Patients Still Alive after 36 Months

    "(p-value = 0.01, hazard ratio = 1.7). This hazard ratio implies that patients receiving placebo have a relative risk of dying that is 70 percent higher than those patients receiving Provenge. In addition, 34 percent of patients receiving Provenge were alive at 36 months compared to 11 percent of patients receiving placebo (p-value = 0.0046). The survival benefit seen with Provenge was independent of a patient's Gleason Score, a common measure of disease severity. Provenge was well tolerated with the most common adverse events reported being fever and chills lasting for one to two days"

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.690.00(0.00%)Apr 16 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.